ABOUT THIS EPISODE
Excedr provides research labs with equipment leases on founder-friendly terms to support paths to exceptional outcomes. Learn more at https://www.excedr.com/partners.
“Knowledge is now a commodity, and it's your ability to ask the right question and the right next question that is really where the value is.”
“Knowledge is now a commodity, and it's your ability to ask the right question and the right next question that is really where the value is.”
Scott Chetham explains why he left academia, how applied physics and industry-sponsored research prepared him for commercial healthcare, and what he learned leading technology and commercialization at ImpediMed. He discusses lymphedema detection, body composition monitoring, early GLP-1 research, and the long path from clinical measurement to drug development.
The conversation then turns to scaling teams through uncertainty. Scott shares how company growth creates organizational whiplash, why founders often underestimate the need for change management, and how leaders can stay close to what employees and customers are actually experiencing.
Scott also describes the shift from software and AI as coding problems to problems of product judgment, prioritization, alignment, and quality assurance. He outlines how better automation could cut roughly half the internal work involved in clinical development, while explaining why rigorous verification and human decision-making remain essential.
Key Topics Covered:
- Leaving academia for direct impact in healthcare
- Applied physics, biomedical engineering, and industry-sponsored research
- How asking the right scientific question shapes clinical development
- ImpedMed's lymphedema detection technology
- Body composition monitoring in obesity and drug research
- Early GLP-1 clinical research and pharmaceutical partnerships
- The progression from diagnostic devices to clinical development software
- Change management inside fast-growing healthcare companies
- Founder comfort with uncertainty, pivots, and execution
- Keeping leadership connected to employees as teams scale
- AI-driven shifts in product development and engineering bottlenecks
- Front-loading quality assurance for regulated workflows
- Reducing clinical development time, labor, and cost
If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening.
Listen and subscribe to The Biotech Startups Podcast:
Apple Podcasts: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994
Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4
TBSP YouTube: https://www.youtube.com/@thebiotechstartupspodcast
TBSP website: https://www.thebiotechstartupspodcast.com/?utm_source=podcast&utm_medium=show-notes&utm_campaign=the-biotech-startups-podcast-ep285
Find our guest, Scott Chetham, at these links:
LinkedIn: https://www.linkedin.com/in/scott-chetham-2949001
Website: https://farohealth.com/
Find our host, Jon Chee, at these links:
LinkedIn: https://www.linkedin.com/in/jonchee/
Learn more about Excedr:
LinkedIn: https://www.linkedin.com/company/excedr/
Website: https://www.excedr.com
Intro & Outro Songs Created by OkKyojin:
https://flow.page/kyojin
Resources & Articles:
ImpediMed: https://impedimed.com/
Novo Nordisk: https://www.novonordisk.com/
ClinicalTrials.gov: https://clinicaltrials.gov/
Google X: https://x.company/
Verily: https://verily.com/
Companies, Universities, & People Mentioned:
ImpediMed: https://impedimed.com/
Novo Nordisk: https://www.novonordisk.com/
Novartis: https://www.novartis.com/
Versant Ventures: https://www.versantventures.com/
Google: https://www.google.com/
Google X: https://x.company/
Verily: https://verily.com/
DeepMind: https://deepmind.google/
Meta: https://about.meta.com/
Timestamps:
00:00 Intro
01:36 Why Scott Left Academia
03:42 Applied Physics in Clinical Research
04:52 The Value of Asking Better Questions
04:56 From Research to Industry
07:17 Scaling Through Change Management
09:30 The Whiplash of Company Growth
13:20 Staying Close to the Front Line
15:46 ImpedMed's Clinical Applications
19:14 Following the Clinical Research Thread
20:25 How Google Changed the Thesis
24:00 The New Prioritization Problem
27:24 Why QA Must Come First
30:46 The Economics of Faster Development
32:46 Outro
The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of The Biotech Startups Podcast.
OTHER EPISODES IN THIS PODCAST
Excedr provides research labs with equipment leases on founder-friendly terms to support paths to exceptional outcomes. Learn more at https://www.excedr.com/partners.“Our problem is the clinical funnel to shove things through this 12 year development cycle and the amount of capital it takes.”
Clin…
Excedr provides research labs with equipment leases on founder-friendly terms to support paths to exceptional outcomes. Learn more at https://www.excedr.com/partners.“Two-thirds of our work is QA. It's not the development anymore. It's how do you ensure it's doing what you think it's doing and that…
Excedr helps life science companies get the lab equipment they need through flexible leasing. Skip the upfront costs, stay lean, and focus on breakthrough science.
As a TBSP listener, you can get exclusive perks through Excedr's partner network: special savings, promotions, and more. Explore these…
Excedr provides research labs with equipment leases on founder-friendly terms to support paths to exceptional outcomes. Learn more at https://www.excedr.com/partners.“If things are getting more complex, you're going in the wrong direction.”
Scott Chetham explains why he left Google and Verily to t…
Disclaimer: The podcast and artwork embedded on this page are from Excedr, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.